ArticleCancer2017
Population-based cancer survival in the United States: Data, quality control, and statistical methods.
Article in Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Initial Data Analysis for Cancer Registries: A Structured Framework and Demonstration Using Slovenian Cancer Registry Data.Cancers · 2026Article
- Trends over 48 years in a one-number index of survival for all cancers combined, England and Wales (1971-2018): a population-based registry study.The Lancet regional health. Europe · 2025Article
- Survival differences between the USA and an urban population from China for all cancer types and 20 individual cancers: a population-based study.The Lancet regional health. Western Pacific · 2023Article
- Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3).Neuro-oncology · 2023Article
- Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study.Cancer communications (London, England) · 2023Article
- Cancer survival: left truncation and comparison of results from hospital-based cancer registry and population-based cancer registry.Frontiers in oncology · 2023Article
- Identifying Factors Associated with Loss to Follow-up Among Patients Reported to the New York State Cancer Registry.Journal of registry management · 2022Article
- Population-Based Cancer Survival in Canada and the United States by Socioeconomic Status: Findings from the CONCORD-2 Study.Journal of registry management · 2022Article
- Disparities in cervical cancer survival in the United States by race and stage at diagnosis: An analysis of 138,883 women diagnosed between 2001 and 2014 (CONCORD-3).Gynecologic oncology · 2021Article
- The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).Neuro-oncology · 2021Article
- Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014.Neuro-oncology practice · 2020Article
- Evaluating the quality of data from the Japanese National Clinical Database 2011 via a comparison with regional government report data and medical charts.Surgery today · 2019Article
- Cancer Survival by Stage at Diagnosis in Kuwait: A Population-Based Study.Journal of oncology · 2019Article
- Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.Lancet (London, England) · 2018Article
- Article
- Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
- Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
- Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
- Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
- Population-based cancer survival (2001 to 2009) in the United States: Findings from the CONCORD-2 study.Cancer · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundRobust comparisons of population-based cancer survival estimates require tight adherence to the study protocol, standardized quality control, appropriate life tables of background mortality, and centralized analysis. The CONCORD program established worldwide surveillance of population-based cancer survival in 2015, analyzing individual data on 26 million patients (including 10 million US patients) diagnosed between 1995 and 2009 with 1 of 10 common malignancies.
methodsIn this Cancer supplement, we analyzed data from 37 state cancer registries that participated in the second cycle of the CONCORD program (CONCORD-2), covering approximately 80% of the US population. Data quality checks were performed in 3 consecutive phases: protocol adherence, exclusions, and editorial checks. One-, 3-, and 5-year age-standardized net survival was estimated using the Pohar Perme estimator and state- and race-specific life tables of all-cause mortality for each year. The cohort approach was adopted for patients diagnosed between 2001 and 2003, and the complete approach for patients diagnosed between 2004 and 2009.
resultsArticles in this supplement report population coverage, data quality indicators, and age-standardized 5-year net survival by state, race, and stage at diagnosis. Examples of tables, bar charts, and funnel plots are provided in this article.
conclusionsPopulation-based cancer survival is a key measure of the overall effectiveness of services in providing equitable health care. The high quality of US cancer registry data, 80% population coverage, and use of an unbiased net survival estimator ensure that the survival trends reported in this supplement are robustly comparable by race and state. The results can be used by policymakers to identify and address inequities in cancer survival in each state and for the United States nationally. Cancer 2017;123:4982-93. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.